{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T05:22:30Z","timestamp":1734758550023,"version":"3.32.0"},"reference-count":19,"publisher":"Pharmaceutical Society of Japan","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2024,7,23]]},"DOI":"10.1248\/bpb.b24-00207","type":"journal-article","created":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T22:10:21Z","timestamp":1721686221000},"page":"1326-1330","source":"Crossref","is-referenced-by-count":1,"title":["Incidence of Fatigue Following Dexamethasone Administration for Supportive Therapy and Efficacy of Tapering in Perioperative Chemotherapy for Breast Cancer: A Retrospective Observational Study"],"prefix":"10.1248","volume":"47","author":[{"given":"Naoki","family":"Yabuta","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Shiga University of Medical Science Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Noda","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Shiga University of Medical Science Hospital"},{"name":"College of Pharmaceutical Sciences, Ritsumeikan University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatomo","family":"Sudo","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Shiga University of Medical Science Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinori","family":"Wakasugi","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Shiga University of Medical Science Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Morii","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Shiga University of Medical Science Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaori","family":"Tomida","sequence":"additional","affiliation":[{"name":"Department of Surgery, Shiga University of Medical Science"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin-ya","family":"Morita","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Shiga University of Medical Science Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"doi-asserted-by":"crossref","unstructured":"1) Aogi K, Takeuchi H, Saeki T, <i>et al.<\/i> Optimizing antiemetic treatment for chemotherapy-induced nausea and vomiting in Japan: update summary of the 2015 Japan Society of Clinical Oncology Clinical Practice Guidelines for Antiemesis. <i>Int. J. Clin. Oncol.<\/i>, <b>26<\/b>, 1\u201317 (2021).","key":"1","DOI":"10.1007\/s10147-020-01818-3"},{"doi-asserted-by":"crossref","unstructured":"2) Jones SE, Erban J, Overmoyer B, Budd GT, Hutchins L, Lower E, Laufman L, Sundaram S, Urba WJ, Pritchard KI, Mennel R, Richards D, Olsen S, Meyers ML, Ravdin PM. Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer. <i>J. Clin. Oncol.<\/i>, <b>23<\/b>, 5542\u20135551 (2005).","key":"2","DOI":"10.1200\/JCO.2005.02.027"},{"doi-asserted-by":"crossref","unstructured":"3) Harvey V, Mouridsen H, Semiglazov V, Jakobsen E, Voznyi E, Robinson BA, Groult V, Murawsky M, Cold S. Phase III trial comparing three doses of docetaxel for second-line treatment of advanced breast cancer. <i>J. Clin. Oncol.<\/i>, <b>24<\/b>, 4963\u20134970 (2006).","key":"3","DOI":"10.1200\/JCO.2005.05.0294"},{"doi-asserted-by":"crossref","unstructured":"4) Chan S, Winterbottom L, Gardner S. Response to dexamethasone in patients with fluid retention after docetaxel. <i>Lancet<\/i>, <b>347<\/b>, 1486\u20131487 (1996).","key":"4","DOI":"10.1016\/S0140-6736(96)91723-7"},{"doi-asserted-by":"crossref","unstructured":"5) Hosonaga M, Ito Y, Tokudome N, Takahashi S, Iwase T, Hatake K. A lower dose of docetaxel at 60\u2009mg\/m<sup>2<\/sup> could be continued longer for controlling peripheral edema in patients with metastatic breast cancer. <i>Breast Cancer<\/i>, <b>19<\/b>, 329\u2013334 (2012).","key":"5","DOI":"10.1007\/s12282-011-0297-y"},{"doi-asserted-by":"crossref","unstructured":"6) Prete A, Bancos I. Glucocorticoid induced adrenal insufficiency. <i>BMJ<\/i>, <b>374<\/b>, n1380 (2021).","key":"6","DOI":"10.1136\/bmj.n1380"},{"doi-asserted-by":"crossref","unstructured":"7) Gruber LM, Bancos I. Secondary adrenal insufficiency: recent updates and new directions for diagnosis and management. <i>Endocr. Pract.<\/i>, <b>28<\/b>, 110\u2013117 (2022).","key":"7","DOI":"10.1016\/j.eprac.2021.09.011"},{"doi-asserted-by":"crossref","unstructured":"8) Spiegel RJ, Vigersky RA, Oliff AI, Echelberger CK, Bruton J, Poplack DG. Adrenal suppression after short-term corticosteroid therapy. <i>Lancet<\/i>, <b>313<\/b>, 630\u2013633 (1979).","key":"8","DOI":"10.1016\/S0140-6736(79)91077-8"},{"doi-asserted-by":"crossref","unstructured":"9) Usami E, Kimura M, Yoshimura T, Yasuda T, Teramachi H, Sugiyama T, Tsuchiya T. Steroid withdrawal syndrome after normal dose chemotherapy in Non-Hodgkin\u2019s lymphoma: a study of the frequency of symptoms and the efficacy of steroid tapering. <i>Iryo Yakugaku (Jpn. J. Pharm. Health Care Sci.)<\/i>, <b>38<\/b>, 282\u2013287 (2012).","key":"9","DOI":"10.5649\/jjphcs.38.282"},{"doi-asserted-by":"crossref","unstructured":"10) Richter B, Neises G, Clar C. Glucocorticoid withdrawal schemes in chronic medical disorders: a systematic review. <i>Endocrinol. Metab. Clin. North Am.<\/i>, <b>31<\/b>, 751\u2013778 (2002).","key":"10","DOI":"10.1016\/S0889-8529(02)00008-7"},{"doi-asserted-by":"crossref","unstructured":"11) Han HS, Park JC, Park SY, Lee KT, Bae SB, Kim HJ, Kim S, Yun HJ, Bae WK, Shim HJ, Hwang JE, Cho SH, Park MR, Shim H, Kwon J, Choi MK, Kim ST, Lee KH. A prospective multicenter study evaluating secondary adrenal suppression after antiemetic dexamethasone therapy in cancer patients receiving chemotherapy: a Korean South West Oncology Group study. <i>Oncologist<\/i>, <b>20<\/b>, 1432\u20131439 (2015).","key":"11","DOI":"10.1634\/theoncologist.2015-0211"},{"doi-asserted-by":"crossref","unstructured":"12) Borresen SW, Klose M, Glintborg D, Watt T, Andersen MS, Feldt-Rasmussen U. Approach to the patient with glucocorticoid-induced adrenal insufficiency. <i>J. Clin. Endocrinol. Metab.<\/i>, <b>107<\/b>, 2065\u20132076 (2022).","key":"12","DOI":"10.1210\/clinem\/dgac151"},{"doi-asserted-by":"crossref","unstructured":"13) Schlaghecke R, Kornely E, Santen RT, Ridderskamp P. The effect of long-term glucocorticoid therapy on pituitary-adrenal responses to exogenous corticotropin-releasing hormone. <i>N. Engl. J. Med.<\/i>, <b>326<\/b>, 226\u2013230 (1992).","key":"13","DOI":"10.1056\/NEJM199201233260403"},{"doi-asserted-by":"crossref","unstructured":"14) Henzen C, Suter A, Lerch E, Urbinelli R, Schorno XH, Briner VA. Suppression and recovery of adrenal response after short-term, high-dose glucocorticoid treatment. <i>Lancet<\/i>, <b>355<\/b>, 542\u2013545 (2000).","key":"14","DOI":"10.1016\/S0140-6736(99)06290-X"},{"doi-asserted-by":"crossref","unstructured":"15) Sparano JA, Wang M, Martino S, Jones V, Perez EA, Saphner T, Wolff AC, Sledge GW Jr, Wood WC, Davidson NE. Weekly paclitaxel in the adjuvant treatment of breast cancer. <i>N. Engl. J. Med.<\/i>, <b>358<\/b>, 1663\u20131671 (2008).","key":"15","DOI":"10.1056\/NEJMoa0707056"},{"doi-asserted-by":"crossref","unstructured":"16) Joseph RM, Hunter AL, Ray DW, Dixon WG. Systemic glucocorticoid therapy and adrenal insufficiency in adults: a systematic review. <i>Semin. Arthritis Rheum.<\/i>, <b>46<\/b>, 133\u2013141 (2016).","key":"16","DOI":"10.1016\/j.semarthrit.2016.03.001"},{"doi-asserted-by":"crossref","unstructured":"17) Nakade S, Ohno T, Kitagawa J, Hashimoto Y, Katayama M, Awata H, Kodama Y, Miyata Y. Population pharmacokinetics of aprepitant and dexamethasone in the prevention of chemotherapy-induced nausea and vomiting. <i>Cancer Chemother. Pharmacol.<\/i>, <b>63<\/b>, 75\u201383 (2008).","key":"17","DOI":"10.1007\/s00280-008-0713-y"},{"unstructured":"18) McCrea JB, Majumdar AK, Goldberg MR, Iwamoto M, Gargano C, Panebianco DL, Hesney M, Lines CR, Petty KJ, Deutsch PJ, Murphy MG, Gottesdiener KM, Goldwater DR, Blum RA. Effects of the neurokinin1 receptor antagonist aprepitant on the pharmacokinetics of dexamethasone and methylprednisolone. <i>Clin. Pharmacol. Ther.<\/i>, <b>74<\/b>, 17\u201324 (2003).","key":"18"},{"doi-asserted-by":"crossref","unstructured":"19) Theiler-Schwetz V, Prete A. Glucocorticoid withdrawal syndrome: what to expect and how to manage. <i>Curr. Opin. Endocrinol. Diabetes Obes.<\/i>, <b>30<\/b>, 167\u2013174 (2023).","key":"19","DOI":"10.1097\/MED.0000000000000804"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/47\/7\/47_b24-00207\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T03:36:02Z","timestamp":1734752162000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/47\/7\/47_b24-00207\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,23]]},"references-count":19,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b24-00207","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"type":"print","value":"0918-6158"},{"type":"electronic","value":"1347-5215"}],"subject":[],"published":{"date-parts":[[2024,7,23]]},"article-number":"b24-00207"}}